A detailed history of Oxbow Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Oxbow Advisors, LLC holds 99,959 shares of SNY stock, worth $4.84 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
99,959
Previous 99,726 0.23%
Holding current value
$4.84 Million
Previous $4.84 Million 19.12%
% of portfolio
0.65%
Previous 0.65%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$48.54 - $58.53 $11,309 - $13,637
233 Added 0.23%
99,959 $5.76 Million
Q2 2024

Aug 06, 2024

BUY
$45.39 - $50.36 $155,233 - $172,231
3,420 Added 3.55%
99,726 $4.84 Million
Q1 2024

May 06, 2024

BUY
$45.75 - $52.48 $92,049 - $105,589
2,012 Added 2.13%
96,306 $4.68 Million
Q4 2023

Feb 08, 2024

BUY
$43.13 - $54.79 $4.07 Million - $5.17 Million
94,294 New
94,294 $4.69 Million
Q3 2019

Oct 31, 2019

SELL
$40.34 - $46.64 $1.46 Million - $1.69 Million
-36,294 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$40.43 - $44.3 $50,537 - $55,375
1,250 Added 3.57%
36,294 $1.57 Million
Q1 2019

May 01, 2019

BUY
$40.83 - $45.43 $36,134 - $40,205
885 Added 2.59%
35,044 $1.55 Million
Q4 2018

Feb 12, 2019

SELL
$41.48 - $45.59 $1.69 Million - $1.86 Million
-40,825 Reduced 54.44%
34,159 $1.48 Million
Q3 2018

Nov 06, 2018

SELL
$40.0 - $44.84 $177,840 - $199,358
-4,446 Reduced 5.6%
74,984 $3.35 Million
Q2 2018

Aug 09, 2018

SELL
$37.63 - $41.22 $23,706 - $25,968
-630 Reduced 0.79%
79,430 $3.18 Million
Q1 2018

Apr 30, 2018

BUY
$38.98 - $45.76 $183,400 - $215,300
4,705 Added 6.24%
80,060 $3.21 Million
Q4 2017

Jan 30, 2018

BUY
$42.86 - $50.61 $126,437 - $149,299
2,950 Added 4.07%
75,355 $3.24 Million
Q3 2017

Oct 23, 2017

BUY
$47.04 - $50.34 $3.41 Million - $3.64 Million
72,405
72,405 $3.61 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Oxbow Advisors, LLC Portfolio

Follow Oxbow Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.